Mutational Analysis of HBs Ag-Positive Mothers and Their Infected Children despite Immunoprophylaxis
Abstract
Hepatitis B vaccination is safe and effective, although breakthrough infection occasionally occurs in those who receive the vaccine and hepatitis B immunoglobulin (HBIg) prophylaxis. Sequence variation in their antigenic regions is one of the most powerful strategies that are used by viruses to escape recognition by B and T cell-mediated immune responses. The aim of this study was to explore the mutational profile of HBV in vertical transmission.
Six HBsAg-positive mothers and their children who developed HBV infection despite immunoprophylaxis were enrolled. After extraction of HBV DNA from sera, the full HBV genome or surface gene was amplified by Gunther and hemi-nested PCR, respectively. After sequencing, the mutational analysis on paired samples between mothers and children were carried out and compared.
Different mutations were found in four children; at least, one arose in functional and/or immune epitope activities. Of 30 amino acid changes, 11 (36.6%) were located within the known HBV immune epitopes. In three children, mutations occurred within the “a” determinant region, one mutation (B2) was identical to the mother of patient, an indication of vertical transmission. The other two (B4 and B5) were considered as vaccine escape mutations. Three children harbored wild-type HBsAg, similar to their mothers. Regarding transmission in infected children, the immunoprophylaxis had no effect and failure of vaccination was observed in 2 isolates.
These findings emphasized the need for an alternative regimen, such as the administration of boosters or a more effective HBV vaccine for high-risk children who are born to HBsAg-positive mothers.
1. Visvanathan K, Lewin SR. Immunopathogenesis: role of innate and adaptive immune responses. Semin Liver Dis 2006; 26(2):104-15.
2. Zuckerman JN. Review: hepatitis B immune globulin for prevention of hepatitis B infection. J Med Virol 2007; 79(7):919-21.
3. Moradi A, Khodabakhshi B, Roshandel G, Kalavi K, Besharat S, Semnani S. Response to the Hepatitis B Virus Vaccine in Iranian Infants. Hepat Mon 2009; 9(3):229-31.
4. Salkic NN. Intrafamilial Transmission of Hepatitis B: Experience and Lessons Learned in Bosnia and Herzegovina. Hepat Mon 2009; 9(3):169-70.
5. Yamamoto K, Horikita M, Tsuda F, Itoh K, Akahane Y, Yotsumoto S, et al. Naturally occurring escape mutants of hepatitis B virus with various mutations in the S gene in carriers seropositive for antibody to hepatitis B surface antigen. J Virol 1994; 68(4):2671-6.
6. Carman WF, Korula J, Wallace L, MacPhee R, Mimms L, Decker R. Fulminant reactivation of hepatitis B due to envelope protein mutant that escaped detection by monoclonal HBsAg ELISA. Lancet 1995; 345(8962):1406-7.
7. Carman WF. The clinical significance of surface antigen variants of hepatitis B virus. J Viral Hepat 1997; 4 Suppl 1:11-20.
8. Ghany MG, Ayola B, Villamil FG, Gish RG, Rojter S, Vierling JM, et al. Hepatitis B virus S mutants in liver transplant recipients who were reinfected despite hepatitis B immune globulin prophylaxis. Hepatology 1998; 27(1):213-22.
9. Protzer-Knolle U, Naumann U, Bartenschlager R, Berg T,Hopf U, Meyer zum Buschenfelde KH, et al. Hepatitis B virus with antigenically altered hepatitis B surface antigen is selected by high-dose hepatitis B immune globulin after liver transplantation. Hepatology 1998; 27(1):254-63.
10. Ireland JH, O'Donnell B, Basuni AA, Kean JD, Wallace LA, Lau GK, et al. Reactivity of 13 in vitro expressed hepatitis B surface antigen variants in 7 commercial diagnostic assays. Hepatology 2000; 31(5):1176-82.
11. Weber B. Diagnostic impact of the genetic variability of the hepatitis B virus surface antigen gene. J Med Virol 2006; 78 Suppl 1:S59-65.
12. Hollinger FB, Sood G. Occult hepatitis B virus infection:a covert operation. J Viral Hepat 2010; 17(1):1-15.
13. Hsu HY, Chang MH, Ni YH, Lin HH, Wang SM, Chen DS. Surface gene mutants of hepatitis B virus in infants who develop acute or chronic infections despite immunoprophylaxis. Hepatology 1997; 26(3):786-91.
14. Oon CJ, Chen WN, Goo KS, Goh KT. Intra-familial evidence of horizontal transmission of hepatitis B virus surface antigen mutant G145R. J Infect 2000; 41(3):260-4.
15. Chen WN, Oon CJ, Koh S. Horizontal transmission of a hepatitis B virus surface antigen mutant. J Clin Microbiol 2000; 38(2):938-9.
16. Chen WN, Oon CJ. Hepatitis B virus surface antigen (HBsAg) mutants in Singapore adults and vaccinated children with high anti-hepatitis B virus antibody levels but negative for HBsAg. J Clin Microbiol 2000;38(7):2793-4.
17. Mele A, Tancredi F, Romano L, Giuseppone A, Colucci M, Sangiuolo A, et al. Effectiveness of hepatitis B vaccination in babies born to hepatitis B surface antigen- positive mothers in Italy. J Infect Dis 2001; 184(7):905-8.
18. Friedt M, Gerner P, Wintermeyer P, Wirth S. Complete hepatitis B virus genome analysis in HBsAg positive mothers and their infants with fulminant hepatitis B. BMC Gastroenterol 2004; 4:11.
19. Alavian SM, Hajariazdeh B, Ahmadzad Asl M, Kabir A, Bagheri Lankarani K. Hepatitis B Virus Infection in Iran: A Systematic Review. Hepat Mon 2008; 8(4):281-94.
20. Nokhodian Z, Kassaian N, Ataei B, Javadi AA, Shoaei P, Farajzadegan Z, et al. Hepatitis B Markers in Isfahan, Central Iran: A Population-Based Study. Hepat Mon 2009; 9(1):12-6.
21. Hajiani E, Hashemi S, Masjedizadeh A.Seroepidemiology of Hepatitis B Virus Infection in Khuzestan Province, Southwest of Iran. Hepat Mon 2009;9(1):34-8.
22. Alavian SM. Ministry of Health in Iran Is Serious about Controlling Hepatitis B. Hepat Mon 2007; 7(1):3-5.
23. Alavian SM, Gooya MM, Hajarizadeh B, Esteghamati AR, Moeinzadeh AM, Haghazali M, et al. Mass Vaccination Campaign against Hepatitis B in Adolescents in Iran: Estimating Coverage using Administrative Data. Hepat Mon 2009; 9(3):189-95.
24. Hosseini SM, Ranjbar R, Abolghasemi H, Turkaman M.Evaluation of the Level of HBV Antibody Titer after HBV Vaccination among Children in Tehran, Iran. Hepat Mon 2009; 9(2):150-3.
25. Adibi P, Ghassemian R, Alavian SM, Ranjbar M, Mohammadalizadeh AH, Nematizadeh F, et al. Effectiveness of hepatitis B vaccination in children of chronic hepatitis B mothers. Saudi Med J 2004; 25:1414-18.
26. Estévez ZC, Silva CV, Arias EP. On the Comparison of Two HBV Recombinant Vaccines. Hepat Mon 2010;10(3):223-5.
27. Gunther S, Li BC, Miska S, Kruger DH, Meisel H, Will H. A novel method for efficient amplification of whole hepatitis B virus genomes permits rapid functional analysis and reveals deletion mutants in immunosuppressed patients. J Virol 1995; 69(9):5437-44.
28. Jazayeri M, Basuni AA, Sran N, Gish R, Cooksley G, Locarnini S, et al. HBV core sequence: definition of genotype-specific variability and correlation with geographical origin. J Viral Hepat 2004; 11(6):488-501.
29. Goodarzi Z, Malekzadeh R, Montazeri G, Alavian SM, Qurbanalizadgan M, Daram M, et al. Phylogenetic Analysis of HBV Based on PreS Region in Iranian Hepatocellular Carcinoma Patients. Hepat Mon 2007;7(4):201-5.
30. Liu XH, Lin J, Zhang SH, Zhang SM, Feitelson MA, Gao HJ, et al. COOH-terminal deletion of HBx gene is a frequent event in HBV-associated hepatocellular carcinoma. World J Gastroenterol 2008; 14(9):1346-52.
31. Fujii H, Moriyama K, Sakamoto N, Kondo T, Yasuda K, Hiraizumi Y, et al. Gly145 to Arg substitution in HBs antigen of immune escape mutant of hepatitis B virus. Biochem Biophys Res Commun 1992; 184(3):1152-7.
32. Lee PI, Chang LY, Lee CY, Huang LM, Chang MH.Detection of hepatitis B surface gene mutation in carrier children with or without immunoprophylaxis at birth. J Infect Dis 1997; 176(2):427-30.
33. Carman WF, Zanetti AR, Karayiannis P, Waters J, Manzillo G, Tanzi E, et al. Vaccine-induced escape mutant of hepatitis B virus. Lancet 1990; 336(8711):325-9.
34. Ngui SL, O'Connell S, Eglin RP, Heptonstall J, Teo CG.Low detection rate and maternal provenance of hepatitis B virus S gene mutants in cases of failed postnatal immunoprophylaxis in England and Wales. J Infect Dis 1997; 176(5):1360-5.
35. Ferrari C, Bertoletti A, Penna A, Cavalli A, Valli A, Missale G, et al. Identification of immunodominant T cell epitopes of the hepatitis B virus nucleocapsid antigen. J Clin Invest 1991; 88(1):214-22.
36. Mizukoshi E, Sidney J, Livingston B, Ghany M, Hoofnagle JH, Sette A, et al. Cellular immune responses to the hepatitis B virus polymerase. J Immunol 2004;173(9):5863-71.
37. Mu SC, Lin YM, Jow GM, Chen BF. Occult hepatitis B virus infection in hepatitis B vaccinated children in Taiwan. J Hepatol 2009; 50(2):264-72.
38. Carman WF, Jacyna MR, Hadziyannis S, Karayiannis P, McGarvey MJ, Makris A, et al. Mutation preventing formation of hepatitis B e antigen in patients with chronic hepatitis B infection. Lancet 1989; 2(8663):588-91.
39. Mesenas SJ, Chow WC, Zhao Y, Lim GK, Oon CJ, NgHS. Wild-type and 'a' epitope variants in chronic hepatitis
B virus carriers positive for hepatitis B surface antigen and antibody. J Gastroenterol Hepatol 2002; 17(2):148-52.
40. Schranz P, Zentgraf H, Loncarevic IF, Niepmann M, Schroder CH. Defective replication units of hepatitis B virus. J Virol 1990; 64(4):1851-4.
41. Alexopoulou A, Karayiannis P, Hadziyannis SJ, Aiba N, Thomas HC. Emergence and selection of HBV variants in an anti-HBe positive patient persistently infected with quasi-species. J Hepatol 1997; 26(4):748-53.
42. Guo J, Yao L, Chen A, Xu Y, Liu X, Shu Y, et al. [Immunological evaluation of vector-expressed M2 and HA genes of H5N1 influenza virus in mice]. Sheng Wu Gong Cheng Xue Bao 2010; 26(5):649-56.
43. Hsu HY, Chang MH, Liaw SH, Ni YH, Chen HL.Changes of hepatitis B surface antigen variants in carrier children before and after universal vaccination in Taiwan. Hepatology 1999; 30(5):1312-7.
44. Ogata N, Zanetti AR, Yu M, Miller RH, Purcell RH.
Infectivity and pathogenicity in chimpanzees of a surface gene mutant of hepatitis B virus that emerged in a vaccinated infant. J Infect Dis 1997; 175(3):511-23.
| Files | ||
| Issue | Vol 12, No 4 (2013) | |
| Section | Articles | |
| Keywords | ||
| HBV escape mutants HBV prophylaxis Hepatitis B immunoglobulin | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
